Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
AnPac Bio-Medical Science Acquires GISN (HK) LIMITED, a Technical Solution and Outsourcing Consulting Services Provider 2023-02-15 21:00
Eluminex Biosciences Announces Completion of Initial Enrollment in Part A of the CLARITY Study Evaluating a Human Recombinant Collagen-derived (rhCIII) Biosynthetic Cornea (EB-301) 2023-02-15 01:00
Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for Treatment of Relapsed/Refractory Multiple Myeloma 2023-02-13 20:30
Vmade Launched Cooperation with Fulgent Life to Build a Cross-Border SaaS and Payment Integration Solution for Private Growth 2023-02-13 20:00
HanAll Biopharma Invests in Interon to Seek Collaboration Opportunities 2023-02-10 20:00
Nona Biosciences Enters into HCAb Based Antibody Discovery Collaboration Agreement with Mythic Therapeutics 2023-02-10 13:00
Technoderma Medicines Initiates TDM-180935 Atopic Dermatitis Clinical Program with Phase 1 Dose Escalation Trial 2023-02-09 21:00
AnPac Bio-Medical Science Enters into Definitive Agreement to Acquire Fresh2 Ecommerce Inc, a B2B Asian Food E-commerce Platform 2023-02-09 21:00
GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea 2023-02-09 09:21
ReviR Therapeutics and Asieris Pharmaceuticals Enter into Agreement to Discover Oncology Therapeutics Based on ReviR's Comprehensive Approach to RNA-targeted Technologies 2023-02-08 22:00
SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center 2023-02-08 20:00
Infectious disease specialist Dr. Regis A. Vilchez is appointed CMO of MicuRx Pharmaceuticals, Inc. 2023-02-08 16:05
Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting 2023-02-07 22:00
J INTS BIO, Oral TKI 'JIN-A04', poster presentation of HER2 exon20 insertion mutation in NSCLC 2023-02-07 12:23
Hinova Receives FDA Proceed Authorization for its IND Application for HP518, an Orally Bioavailable Chimeric Degrader Targeting Androgen Receptor for Prostate Cancer Treatment 2023-02-06 21:10
Inmagene receives IND clearance for IMG-008, a long-acting IL-36R mAb 2023-02-06 18:00
Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients 2023-02-06 13:01
Gracell Biotechnologies Announces FDA Clearance of the IND Application for Phase 1b/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Relapsed/Refractory Multiple Myeloma 2023-02-03 20:30
BriSTAR Immunotech to Present at the BIO CEO & Investor Conference 2023-02-02 19:37
CN Energy Group. Inc. Announces Closing of $10 Million Underwritten Public Offering 2023-02-01 22:59
1 58 59 60 61 62 220